Federal Government has disclosed plans to kick-off the immediate vaccination of Nigerians against the Coronavirus disease (Covid-19), in an exercise scheduled to commence before March ending, this year.
Executive Director of the National Primary Health Care Development Agency NPHCDA, Dr. Faisal Shuaib, who disclosed this in a letter to media executives inviting them to a sensitisation meeting on the COVID-19 vaccines, informed that the planned vaccination will deploy employ the widely accepted Pfizer/BioNTech approved COVID-19 vaccines.
“The management of the National Primary Health Care Development Agency NPHCDA wishes to express profound gratitude for your unflinching support to the ongoing effort to stop COVID-19 transmission in Nigeria.
“The Federal Government of Nigeria, through the National Primary Health Care Development Agency NPHCDA with the support of our development partners, is planning to introduce COVID-19 Vaccine from the 1st quarter of 2021, to protect the citizens and stop further spread of the virus in the country.
“This is to inform you that as part of the preparatory activities, NPHCDA has scheduled a sensitisation meeting with media gatekeepers as critical stakeholders in this plan,” the letter read.
The meeting, which would be done via Zoom, is slated for this Friday.
Also confirming the development, President Muhammadu Buhari’s Personal Assistant on New Media, Bashir Ahmad, said, Wednesday, via his official twitter handle (@BashirAhmaad) that Federal Government plans to vaccinate up to 40 per cent of the populace this year and further 30 per cent in 2022.
“Nigeria is expected to get its first batch of COVID-19 (Pfizer-BioNTech) vaccines by the end of this month as part of its plan to inoculate 40% of the population this year and a further 30% next year, Dr Faisal Shuaib, head of the national primary healthcare agency has disclosed,” Ahmad said.
Earlier, Tuesday, Shuaib had at a briefing of the Presidential Taskforce (PTF) on COVID-19 said the country would take delivery of 100,000 doses of the Pfizer/BioNTech approved COVID-19 vaccines by the end of January.
“In the first phase through the COVAX facility, we expect to receive approximately 100,000 doses of the Pfizer and bioNtech vaccine by the end of January”.
According to him, Nigeria expects to receive free 42 million doses of vaccines in the second phase through the COVAX facility being administered by 10 Global Vaccines Alliance, GAVI.
“The second phase will be a combination of all the available approved vaccines currently in the market but this will cover only about 20 percent of Nigeria’s population,” he said.